THNR vs. IBID

Last updated Jun 24, 2026

THNR (Amplify Weight Loss Drug & Treatment ETF) and IBID (iShares iBonds Oct 2027 Term TIPS ETF) are both exchange-traded funds - THNR is a Health & Biotech Equities fund tracking the VettaFi Weight Loss Drug & Treatment Index, while IBID is a Inflation-Protected Bonds fund tracking the ICE 2027 Maturity US Inflation-Linked Treasury Index. Both are passively managed. Over the past year, THNR returned 12.04% vs 3.92% for IBID. At a correlation of -0.02, they often move in opposite directions. THNR charges 0.59%/yr vs 0.10%/yr for IBID.

Performance

THNR vs. IBID - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and iShares iBonds Oct 2027 Term TIPS ETF (IBID). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, THNR achieves a -2.16% return, which is significantly lower than IBID's 1.94% return.

THNR

• 1D: 0.96%
• 1M: -0.39%
• YTD: -2.16%
• 6M: -3.36%
• 1Y: 12.04%
• 3Y*: —
• 5Y*: —
• 10Y*: —

IBID

• 1D: -0.05%
• 1M: -0.25%
• YTD: 1.94%
• 6M: 2.03%
• 1Y: 3.92%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. IBID - Yearly Performance Comparison

	2026 (YTD)	2025	2024
THNR Amplify Weight Loss Drug & Treatment ETF	-2.16%	13.65%	-10.47%
IBID iShares iBonds Oct 2027 Term TIPS ETF	1.94%	5.66%	3.68%

Correlation

The correlation between THNR and IBID is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.09
Correlation (All Time) Calculated using the full available price history since May 21, 2024	-0.02

Return for Risk

THNR vs. IBID — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR

THNR Risk / Return Rank: 20
THNR Sharpe Ratio Rank: 20
THNR Sortino Ratio Rank: 20
THNR Omega Ratio Rank: 19
THNR Calmar Ratio Rank: 23
THNR Martin Ratio Rank: 20

IBID

IBID Risk / Return Rank: 95
IBID Sharpe Ratio Rank: 94
IBID Sortino Ratio Rank: 96
IBID Omega Ratio Rank: 95
IBID Calmar Ratio Rank: 95
IBID Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. IBID - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and iShares iBonds Oct 2027 Term TIPS ETF (IBID). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	THNR	IBID	Difference
Sharpe ratio: Return per unit of total volatility	0.64	3.19	-2.55
Sortino ratio: Return per unit of downside risk	1.05	5.38	-4.34
Omega ratio: Gain probability vs. loss probability	1.12	1.72	-0.60
Calmar ratio: Return relative to maximum drawdown	1.00	7.20	-6.20
Martin ratio: Return relative to average drawdown	2.20	29.14	-26.94

THNR vs. IBID - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.64, which is lower than the IBID Sharpe Ratio of 3.19. The chart below compares the historical Sharpe Ratios of THNR and IBID, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

THNR vs. IBID - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than IBID's maximum drawdown of -1.28%. Use the drawdown chart below to compare losses from any high point for THNR and IBID.

Drawdown Indicators

	THNR	IBID	Difference
Max Drawdown Largest peak-to-trough decline	-32.51%	-1.28%	-31.23%
Max Drawdown (1Y) Largest decline over 1 year	-12.06%	-0.55%	-11.51%
Current Drawdown Current decline from peak	-10.21%	-0.55%	-9.66%
Average Drawdown Average peak-to-trough decline	-12.21%	-0.22%	-11.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.48%	0.13%	+5.35%

Volatility

THNR vs. IBID - Volatility Comparison

Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.73% compared to iShares iBonds Oct 2027 Term TIPS ETF (IBID) at 0.35%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than IBID based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	THNR	IBID	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.73%	0.35%	+5.38%
Volatility (6M) Calculated over the trailing 6-month period	13.69%	0.86%	+12.83%
Volatility (1Y) Calculated over the trailing 1-year period	19.03%	1.23%	+17.80%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.34%	2.24%	+17.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.34%	2.24%	+17.10%

THNR vs. IBID - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is higher than IBID's 0.10% expense ratio.

Dividends

THNR vs. IBID - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.67%, less than IBID's 3.68% yield.

Position	TTM	2025	2024	2023
IBID iShares iBonds Oct 2027 Term TIPS ETF	3.68%	4.43%	4.24%	0.81%
THNR Amplify Weight Loss Drug & Treatment ETF	1.67%	1.64%	0.98%	0.00%

Frequently Asked Questions

Can I hold both THNR and IBID in my portfolio?

THNR and IBID have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, THNR or IBID?

THNR has higher volatility (5.73%) compared to IBID (0.35%). In terms of maximum drawdown, THNR dropped -32.51% vs IBID's -1.28%.

Which ETF is better, THNR or IBID?

On 1-year performance, THNR leads with 12.04% vs 3.92% for IBID. On fees, IBID is cheaper at 0.10% per year. On volatility, IBID has been the lower-risk option at 0.35%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, THNR or IBID?

Over the 1-year period, THNR has performed better with a 12.04% return vs 3.92%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, THNR or IBID?

IBID is cheaper with a 0.10% expense ratio, compared with 0.59% for THNR.

Which ETF pays a higher dividend yield, THNR or IBID?

IBID has the higher dividend yield at 3.68%, compared with 1.67% for THNR.

What is the main difference between THNR and IBID?

THNR is categorized as Health & Biotech Equities, while IBID is Inflation-Protected Bonds. THNR tracks VettaFi Weight Loss Drug & Treatment Index, while IBID tracks ICE 2027 Maturity US Inflation-Linked Treasury Index. They also come from different issuers: Amplify and iShares. Their fees differ too: 0.59% for THNR and 0.10% for IBID.

Which has better risk-adjusted returns?

IBID currently has the higher Sharpe Ratio (3.19 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.